Padlas 60mg Injection
Marketer
Aden Healthcare
Salt Composition
Artesunate (60mg)
Overview Padlas 60mg Injection
Malarex 60mg Injection combats parasitic infections, specifically treating malaria. This injectable medication is not a preventative measure nor effective for severe malaria impacting vital organs (brain, lungs, kidneys). Administration must be performed by a qualified healthcare provider; self-injection is strictly prohibited and reserved for situations where oral intake is infeasible. Common side effects include headache, lightheadedness, fatigue, and decreased appetite, alongside potential injection site reactions such as soreness, inflammation, or discoloration. Persistent symptoms warrant immediate medical attention. Post-treatment, regular blood tests (weekly for four weeks) may be required to monitor parasite levels.
Uses of Padlas 60mg Injection
Plasmodium infection
Major Benefits of Padlas 60mg Injection:
This medication will be administered by your physician or their qualified assistant; self-medication is strictly prohibited.
Common Side effects of Padlas 60mg Injection:
- Headache
- Dizziness
- Weakness
- Loss of appetite
- Injection site reactions (pain, swelling, redness)
How to use Padlas 60mg Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
How Padlas 60mg Injection works:
Malaria is combated by the injection Padlas 60mg, an antiparasitic drug. Its mechanism involves generating intracellular free radicals within the parasite, leading to its destruction.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Padlas 60mg Injection may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Padlas 60mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of Padlas 60mg Injection while breastfeeding appears to pose minimal risk. Available human data indicate a low likelihood of significant harm to the infant.
DrivingUNSAFE
Administering Padlas 60mg Injection might reduce vigilance, impair visual acuity, or induce drowsiness and dizziness. Driving should be avoided if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Padlas 60mg Injection's use in patients suffering from renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Padlas 60mg Injection's use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Padlas 60mg Injection :
Omit a Padlas 60mg Injection dose? Seek your physician's advice.
Facts to Know About Padlas 60mg Injection
| Label | Value |
|---|---|
| Type of Compound | Sesquiterpenoid lactones |
| Addictive | None. |
| Medication Classification | Antimalarial medications |
| Mechanism of Action | Malaria treatment: Artemisinin-based drugs |
3,018 People bought this recently